Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/24 19:43 | 11/11/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Thompson Travis Alvin | X0 | O | Chief Ac | 6 | S.d | -179 | 24.26 | 0 | -7 | 23 | D | |||||||||||||||
10/4/24 16:50 | 10/3/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Lee Kevin | X0 | DO | CEO | 5 | S.d | -391 | 19.82 | 0 | -20 | 390 | D | |||||||||||||||
10/4/24 16:50 | 10/3/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Hannay Michael Charles Ferguson | X0 | O | CHIEF PR | 3 | S | -16 | 21.48 | 0 | -1 | 23 | D | |||||||||||||||
10/4/24 16:50 | 10/3/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Skynner Michael | X0 | O | CTO | 5 | S.d | -118 | 19.81 | 0 | -6 | 96 | D | |||||||||||||||
10/4/24 16:50 | 10/3/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Milnes Alistair | X0 | O | COO | 5 | S.d | -118 | 19.81 | 0 | -6 | 73 | D | |||||||||||||||
10/4/24 16:50 | 10/3/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Crockett Nigel | X0 | O | Chief Bu | 5 | S.d | -118 | 19.81 | 0 | -6 | 49 | D | |||||||||||||||
7/8/24 18:55 | 7/3/24 | BCYC | Health | Drug | Pharmaceutical Preparations | Keen Nicholas | X0 | O | Chief Sc | 4 | S.d | -86 | 19.14 | 0 | -4 | 71 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |